This FCT funded project entitled “Development of potent and broadly neutralizing antibodies fragments for COVID-19 derived from domestic cats naturally infected with SARS-CoV-2” (COVID_CATbodies) aims at contributing to the development of a new generation of neutralizing antibodies for COVID-19 and for upcoming outbreaks. A multidisciplinary team from 4 academic institutions of research excellence from the University of Lisbon (FMV, iMed, iMM-JLA and C2TN/IST) and a Portuguese Biopharmaceutical, TechnoPhage, participate in the project.
Coordinator at IST: Lurdes Gano – lgano@ctn.tecnico.ulisboa.pt